SUPPLEMENT

Q1 2023 — Financial statements (US GAAP)

Q1 2023PDF · 8 pages111 KB
ASML - Summary US GAAP Consolidated Statements of Operations
Three months ended,
Apr 3, Apr 2,
(unaudited, in millions €, except per share data) 2022 2023
Net system sales 2,287.2 5,341.8
Net service and field option sales 1,247.2 1,404.4
Total net sales 3,534.4 6,746.2
Total cost of sales (1,803.4) (3,333.0)
Gross profit 1,731.0 3,413.2
Research and development costs (738.7) (947.9)
Selling, general and administrative costs (207.7) (260.3)
Income from operations 784.6 2,205.0
Interest and other, net (15.6) 12.2
Income before income taxes 769.0 2,217.2
Income tax expense (114.4) (302.6)
Income after income taxes 654.6 1,914.6
Profit related to equity method investments 40.7 41.2
Net income 695.3 1,955.8
Basic net income per ordinary share 1.73 4.96
Diluted net income per ordinary share 1.73 4.95
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 401.1 394.5
Diluted 401.5 394.8
ASML - Ratios and Other Data
Three months ended,
Apr 3, Apr 2,
(unaudited, in millions €, except otherwise indicated) 2022 2023
Gross profit as a percentage of net sales 49.0 % 50.6 %
Income from operations as a percentage of net sales 22.2 % 32.7 %
Net income as a percentage of net sales 19.7 % 29.0 %
Income taxes as a percentage of income before income taxes 14.9 % 13.6 %
Shareholders’ equity as a percentage of total assets 29.1 % 27.8 %
Sales of lithography systems (in units) 1 62 100
Value of booked systems 2 6,977 3,752
Number of payroll employees in FTEs 30,861 37,704
Number of temporary employees in FTEs 2,329 2,816
1. Lithography systems do not include metrology and inspection systems.
2. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

-- 1 of 8 --

ASML - Summary US GAAP Consolidated Balance Sheets
Dec 31, Apr 2,
(unaudited, in millions €) 2022 2023
ASSETS
Cash and cash equivalents 7,268.3 6,647.7
Short-term investments 107.7 4.8
Accounts receivable, net 5,323.8 3,454.7
Finance receivables, net 1,356.7 1,349.2
Current tax assets 33.4 253.6
Contract assets 131.9 236.4
Inventories, net 7,199.7 7,392.0
Other assets 1,643.4 1,722.4
Total current assets 23,064.9 21,060.8
Finance receivables, net — 58.3
Deferred tax assets 1,672.8 1,667.4
Loan receivable 364.4 364.4
Other assets 739.8 1,012.8
Equity method investments 923.6 969.6
Goodwill 4,555.6 4,555.6
Other intangible assets, net 842.4 813.7
Property, plant and equipment, net 3,944.2 4,354.8
Right-of-use assets 192.7 290.2
Total non-current assets 13,235.5 14,086.8
Total assets 36,300.4 35,147.6
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 17,983.6 16,948.1
Total current liabilities 17,983.6 16,948.1
Long-term debt 3,514.2 3,536.0
Deferred and other tax liabilities 267.0 293.0
Contract liabilities 5,269.9 4,147.4
Accrued and other liabilities 454.9 436.8
Total non-current liabilities 9,506.0 8,413.2
Total liabilities 27,489.6 25,361.3
Total shareholders’ equity 8,810.8 9,786.3
Total liabilities and shareholders’ equity 36,300.4 35,147.6

-- 2 of 8 --

ASML - Summary US GAAP Consolidated Statements of Cash Flows
Three months ended,
Apr 3, Apr 2,
(unaudited, in millions €) 2022 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 695.3 1,955.8
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 131.0 170.3
Impairment and loss (gain) on disposal 12.1 3.2
Share-based compensation expense 11.5 18.3
Inventory reserves 50.2 81.7
Deferred tax expense (benefit) (39.7) 12.7
Equity method investments (47.5) (46.8)
Changes in assets and liabilities (1,399.0) (1,461.6)
Net cash provided by (used in) operating activities (586.1) 733.6
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (240.1) (532.0)
Purchase of intangible assets (11.5) (7.4)
Purchase of short-term investments (19.6) (18.2)
Maturity of short-term investments 259.5 121.1
Net cash provided by (used in) investing activities (11.7) (436.5)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid — (541.1)
Purchase of treasury shares (2,038.2) (396.2)
Net proceeds from issuance of shares 21.5 22.7
Repayment of debt and finance lease obligations (13.5) (1.5)
Net cash provided by (used in) financing activities (2,030.2) (916.1)
Net cash flows (2,628.0) (619.0)
Effect of changes in exchange rates on cash 0.3 (1.6)
Net increase (decrease) in cash and cash equivalents (2,627.7) (620.6)
Cash and cash equivalents at beginning of the period 6,951.8 7,268.3
Cash and cash equivalents at end of the period 4,324.1 6,647.7

-- 3 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of
Operations
Three months ended,
Apr 3, Jul 3, Oct 2, Dec 31, Apr 2,
(unaudited, in millions €, except per share data) 2022 2022 2022 2022 2023
Net system sales 2,287.2 4,140.5 4,254.7 4,747.9 5,341.8
Net service and field option sales 1,247.2 1,290.0 1,523.6 1,682.3 1,404.4
Total net sales 3,534.4 5,430.5 5,778.3 6,430.2 6,746.2
Total cost of sales (1,803.4) (2,766.0) (2,784.6) (3,119.3) (3,333.0)
Gross profit 1,731.0 2,664.5 2,993.7 3,310.9 3,413.2
Research and development costs (738.7) (789.1) (819.4) (906.3) (947.9)
Selling, general and administrative costs (207.7) (222.0) (235.8) (280.4) (260.3)
Income from operations 784.6 1,653.4 1,938.5 2,124.2 2,205.0
Interest and other, net (15.6) (10.8) (15.1) (3.1) 12.2
Income before income taxes 769.0 1,642.6 1,923.4 2,121.1 2,217.2
Benefit from (provision for) income taxes (114.4) (246.2) (252.0) (357.3) (302.6)
Income after income taxes 654.6 1,396.4 1,671.4 1,763.8 1,914.6
Profit related to equity method investments 40.7 14.5 30.1 52.7 41.2
Net income 695.3 1,410.9 1,701.5 1,816.5 1,955.8
Basic net income per ordinary share 1.73 3.54 4.29 4.60 4.96
Diluted net income per ordinary share 1.73 3.54 4.29 4.60 4.95
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 401.1 398.3 396.2 394.9 394.5
Diluted 401.5 398.6 396.6 395.2 394.8
ASML - Quarterly Summary Ratios and other data
Apr 3, Jul 3, Oct 2, Dec 31, Apr 2,
(unaudited, in millions €, except otherwise indicated) 2022 2022 2022 2022 2023
Gross profit as a percentage of net sales 49.0 % 49.1 % 51.8 % 51.5 % 50.6 %
Income from operations as a percentage of net sales 22.2 % 30.4 % 33.5 % 33.0 % 32.7 %
Net income as a percentage of net sales 19.7 % 26.0 % 29.4 % 28.2 % 29.0 %
Income taxes as a percentage of income before income taxes 14.9 % 15.0 % 13.1 % 16.8 % 13.6 %
Shareholders’ equity as a percentage of total assets 29.1 % 24.0 % 24.3 % 24.3 % 27.8 %
Sales of lithography systems (in units) 1 62 91 86 106 100
Value of booked systems 2 6,977 8,461 8,920 6,316 3,752
Number of payroll employees in FTEs 30,861 32,627 34,720 36,112 37,704
Number of temporary employees in FTEs 2,329 2,689 2,875 2,974 2,816
1. Lithography systems do not include metrology and inspection systems.
2. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

-- 4 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets
Apr 3, Jul 3, Oct 2, Dec 31, Apr 2,
(unaudited, in millions €) 2022 2022 2022 2022 2023
ASSETS
Cash and cash equivalents 4,324.1 4,096.5 3,152.8 7,268.3 6,647.7
Short-term investments 398.5 305.4 210.0 107.7 4.8
Accounts receivable, net 3,494.6 5,376.7 5,840.2 5,323.8 3,454.7
Finance receivables, net 1,267.6 1,233.1 1,399.4 1,356.7 1,349.2
Current tax assets 811.0 658.0 305.6 33.4 253.6
Contract assets 371.3 270.4 276.9 131.9 236.4
Inventories, net 6,073.5 6,367.1 6,884.0 7,199.7 7,392.0
Other assets 1,468.2 1,528.1 1,657.5 1,643.4 1,722.4
Total current assets 18,208.8 19,835.3 19,726.4 23,064.9 21,060.8
Finance receivables, net 191.5 — 174.9 — 58.3
Deferred tax assets 1,141.9 1,240.8 1,599.6 1,672.8 1,667.4
Loan receivable 124.4 124.4 364.4 364.4 364.4
Other assets 809.8 752.9 745.2 739.8 1,012.8
Equity method investments 940.0 961.4 998.7 923.6 969.6
Goodwill 4,555.6 4,555.6 4,555.6 4,555.6 4,555.6
Other intangible assets, net 923.4 896.1 870.1 842.4 813.7
Property, plant and equipment, net 3,159.4 3,357.7 3,561.7 3,944.2 4,354.8
Right-of-use assets 177.1 188.4 206.9 192.7 290.2
Total non-current assets 12,023.0 12,077.3 13,077.1 13,235.5 14,086.8
Total assets 30,231.8 31,912.6 32,803.5 36,300.4 35,147.6
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 13,612.8 14,637.0 15,668.6 17,983.6 16,948.1
Total current liabilities 13,612.8 14,637.0 15,668.6 17,983.6 16,948.1
Long-term debt 3,951.7 4,385.3 3,503.1 3,514.2 3,536.0
Deferred and other tax liabilities 262.2 252.4 283.0 267.0 293.0
Contract liabilities 3,292.2 4,630.6 4,918.6 5,269.9 4,147.4
Accrued and other liabilities 302.5 358.7 475.1 454.9 436.8
Total non-current liabilities 7,808.6 9,627.0 9,179.8 9,506.0 8,413.2
Total liabilities 21,421.4 24,264.0 24,848.4 27,489.6 25,361.3
Total shareholders’ equity 8,810.4 7,648.6 7,955.1 8,810.8 9,786.3
Total liabilities and shareholders’ equity 30,231.8 31,912.6 32,803.5 36,300.4 35,147.6

-- 5 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash
Flows
Three months ended,
Apr 3, Jul 3, Oct 2, Dec 31, Apr 2,
(unaudited, in millions €) 2022 2022 2022 2022 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 695.3 1,410.9 1,701.5 1,816.5 1,955.8
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 131.0 131.5 137.9 183.2 170.3
Impairment and loss (gain) on disposal 12.1 0.3 13.2 13.7 3.2
Share-based compensation expense 11.5 13.9 22.5 21.0 18.3
Inventory reserves 50.2 75.2 81.8 71.3 81.7
Deferred tax expense (benefit) (39.7) (94.7) (340.8) (89.0) 12.7
Equity method investments (47.5) (21.2) (36.8) 120.8 (46.8)
Changes in assets and liabilities (1,399.0) 1,037.0 (409.8) 3,213.0 (1,461.6)
Net cash provided by (used in) operating activities (586.1) 2,552.9 1,169.5 5,350.5 733.6
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (240.1) (231.5) (356.6) (453.6) (532.0)
Purchase of intangible assets (11.5) (6.0) (7.7) (12.3) (7.4)
Purchase of short-term investments (19.6) (206.4) (104.1) (4.2) (18.2)
Maturity of short-term investments 259.5 299.6 199.5 106.1 121.1
Loans issued and other investments — — (240.0) — —
Net cash provided by (used in) investing activities (11.7) (144.3) (508.9) (364.0) (436.5)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid — (1,475.3) (543.5) (541.1) (541.1)
Purchase of treasury shares (2,038.2) (1,178.5) (1,087.9) (335.0) (396.2)
Net proceeds from issuance of shares 21.5 21.5 19.9 18.9 22.7
Net proceeds from issuance of notes, net of issuance costs — 495.6 — — —
Repayment of debt and finance lease obligations (13.5) (500.7) (1.2) (0.8) (1.5)
Net cash provided by (used in) financing activities (2,030.2) (2,637.4) (1,612.7) (858.0) (916.1)
Net cash flows (2,628.0) (228.8) (952.1) 4,128.5 (619.0)
Effect of changes in exchange rates on cash 0.3 1.2 8.4 (13.0) (1.6)
Net increase (decrease) in cash and cash equivalents (2,627.7) (227.6) (943.7) 4,115.5 (620.6)
Cash and cash equivalents at beginning of the period 6,951.8 4,324.1 4,096.5 3,152.8 7,268.3
Cash and cash equivalents at end of the period 4,324.1 4,096.5 3,152.8 7,268.3 6,647.7

-- 6 of 8 --

Notes to the Summary US GAAP Consolidated Financial Statements
Basis of preparation
The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the
accounting principles generally accepted in the United States of America ("US GAAP").
For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these
interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial
Statements and Notes included within our 2022 Annual Report based on US GAAP, which is available on www.asml.com.

-- 7 of 8 --

Forward Looking Statements
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including
trends in semiconductor end markets and technology industry and business environment trends, statements with respect to
demand and capacity, plans to increase capacity and capacity goals, outlook, backlog, bookings and orders, expected financial
results, including expected growth in sales and gross margin for 2023 and expected net sales, gross margin, R&D costs, SG&A
costs for Q2 2023 and estimated annualized effective tax rate for Q2 and full year 2023, expected system shipments in 2023,
statements made at our 2022 Investor Day including revenue and gross margin opportunity for 2025 and 2030, statements with
respect to fast shipments including estimates of amounts of deferred revenue not yet recognized and expected timing of
recognition of such deferred revenue for fast shipments, expected customer demand trends, statements with respect to export
control policy and regulations and expected impact on us, statements with respect to capital allocation policy including plans to
return significant amounts of cash thought growing dividends and buybacks and statements with respect to the final 2022
dividend and statements with respect to share buyback programs, aim to improve performance on ESG sustainability and
upgrade ESG sustainability strategy and other non-historical statements. You can generally identify these statements by the use
of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast",
"potential", "intend", "continue", "target", "future", "progress", "goal" and variations of these words or comparable words. These
statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about
our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements
do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These
risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry
capacity, worldwide demand and manufacturing capacity utilization for semiconductors, trends in the semi-conductor industry,
the impact of general economic conditions including the impact of the current macroeconomic uncertainty in the market and in
consumer confidence, inflation, interest rates, geopolitical developments, the risk of a recession, demand for our customers'
products, performance of our systems, the impact of COVID-19 and other pandemics and measures taken to contain them, the
impact of the Russian military actions in the Ukraine and measures taken in response on the global economy and global financial
markets and other factors that may impact ASML's financial results, including semiconductor inventory levels, customer demand
including changes in demand for semiconductors and lithography tools, ASML's ability to obtain parts and components for its
products and otherwise meet demand, the success of technology advances and the pace of new product development and
customer acceptance of and demand for new products, production capacity and our ability to meet demand, the impact of
inflation, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or
push outs, supply chain capacity and constraints and logistics and constraints on our ability to produce systems to meet
demand, the timing of recognition of deferred revenue from fast shipments and impact on our results, our ability to enforce
patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, availability of raw
materials, critical manufacturing equipment and qualified employees, trade environment, import/export and national security
regulations and orders and their impact on us including the expected impact of recent and expected changes in export
regulations, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our
indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share
repurchases, results of the share repurchase programs, our ability to meet ESG goals and improve performance on ESG
Sustainability and upgrade ESG strategy and other risks indicated in the risk factors included in ASML's Annual Report on Form
20-F for the year ended December 31, 2022 and other filings with and submissions to the US Securities and Exchange
Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to
update any forward-looking statements after the date of this report or to conform such statements to actual results or revised
expectations, except as required by law.

-- 8 of 8 --